Cancer discovery news
Our researchers are making the discoveries that defeat cancer. Read the latest findings from our world-leading research.
Visit our main news hub to read about news on new funding, our fundraising activities and much more. If you want to keep updated on our news, you can follow us on social media or sign up for our Search newsletter.
If you’re a journalist and want to find out more, you can contact our media relations team.
Gene test predicts likelihood of stomach or oesophageal cancer relapse
A new test could improve care for patients with stomach or oesophageal cancer by predicting their likelihood of relapse after chemotherapy and surgery.
Weight loss drug could help treat advanced ovarian cancer
A weight loss drug available over the counter in the UK could help women with treatment-resistant ovarian cancer respond to chemotherapy again, a new study suggests.
Scientists uncover why testicular cancer runs in families
Testicular cancer in families is usually caused by the accumulation of minor genetic changes that have only a small effect on their own, but together can add up to a significant risk.
Targeting inflammation could help treat drug-resistant bowel cancer
Some bowel cancers that are resistant to treatment could be re-sensitised using drugs that reduce inflammation, according to new research.
Call for hospitals to use high-tech scans to diagnose prostate cancers when they can still be cured
Modern, sophisticated scans should be used in hospitals to pick out men whose prostate cancers have only spread to a limited number of sites, so they can be offered the chance of cure, a new assessment concludes.
How our supporters are helping us take on ‘stealth’ cancers
Professor Raj Chopra, Head of Cancer Therapeutics, thanked ICR supporters and spoke about his hopes for the future for cancer treatment – made possible by their support.
Patients with HPV-positive throat cancer should keep taking chemotherapy
Patients with human papillomavirus (HPV)-positive throat cancer should carry on receiving chemotherapy rather than switching to a targeted cancer drug, new clinical trial results have shown.
Public-private sector collaboration the theme as Minister visits The London Cancer Hub
Business Minister Lord Henley has visited The London Cancer Hub to discuss new opportunities for life-sciences businesses to collaborate with world-leading scientists from The Institute of Cancer Research (ICR), London.
Professor Laurence Pearl awarded prestigious Novartis Medal and Prize
Professor Laurence Pearl, Head of the Division of Structural Biology, has been awarded the Novartis Medal and Prize by the Biochemical Society.
ICR thanks star fundraisers for their significant contributions to our research
Bowel cancer patient and fundraiser Tim Morgan and founder of The Chris Lucas Trust, Lynn Lucas, were thanked at the October meeting of the ICR's Discovery Club for their phenomenal fundraising efforts to support our research.
ICR responds to NICE decision on olaparib for women with advanced ovarian cancer
NICE has announced today, its decision not to recommend olaparib for women with advanced ovarian cancer who had previously responded to platinum chemotherapy for six months or longer.
Climb of Life fundraising total hits £1 million
In its 12th year raising money for The Institute of Cancer Research, London, the Climb of Life has reached the tremendous milestone of raising over £1 million.